Treato IQ platform connects pharma companies to Hispanic consumers
Treato’s Treato IQ platform now delivers insights from the Hispanic population, providing a new and valuable resource for pharmaceutical companies wishing to engage with the rapidly growing Hispanic community.
The single largest demographic sub-segment of the American population and comprising about 53 million people, the Hispanic community is one with which many organizations wish to engage.
“Discussing personal issues like health is much more comfortable in one’s own language, and for the bicultural Hispanic community, this often means sharing online in Spanish,” said Ido Hadari, CEO of Treato. “By providing actionable insights from Spanish-language posts on health-related sites, forums and blogs, pharma companies gain understanding of the Hispanic health care consumer, which allows for better health outcomes.”
80% of Hispanic Internet users frequent social media sites, according to Pew Research, and Forrester Research writes that Hispanic people in the U.S. are more than twice as likely as their non-Hispanic counterparts to be content creators and almost twice as likely to write ratings and reviews.
This new, first-to-market business intelligence offered through Treato IQ allows pharmaceutical companies to understand the unique health experiences of the Hispanic market, enabling them to bring value to this key segment while growing their market share.